insights_auto
Why is INO up 213,75%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,89 $
arrow_upward
+213,75%(+1,29) 1D
1,79 $
arrow_downward
-5,29% (-0,10)todayPre-market
Closed: 2 қар., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,99 $
High
2,17 $
Low
1,66 $
Mkt. cap
196,20 млн
Avg. vol.
6,44 млн
Volume
1,29 млн
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-1,17 $
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
Open
1,99 $
High
2,17 $
Low
1,66 $
Mkt. cap
196,20 млн
Avg. vol.
6,44 млн
Volume
1,29 млн
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-1,17 $
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
BioSpace
·
7 сағат бұрын
INOVIO to Report Third Quarter 2026 Financial Results on November 10, 2026
News Corp
·
13 сағат бұрын
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Benzinga
·
14 сағат бұрын
12 Health Care Stocks Moving In Monday's After-Market Session
Yahoo! Finance Canada
·
17 сағат бұрын
Inovio shares surge 229% as FDA approves first commercial product
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc